Singapore Clinical Trial: Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascending Dose Portion and a Phase 2 Open-Label Portion, to Evaluate the Safety and Efficacy of Oral Infigratinib in Infants and Young Children with Achondroplasia

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'Phase 2b, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, Preceded by a Single Ascendi... Read More

Singapore Clinical Trial: A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer Following Recurrence or Progression On or After Treatment with a CDK4/6 Inhibitor

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3 Open-label Randomized Study Assessing the Efficacy and Safety of RLY-2608 + Fulvestrant V... Read More

Singapore Clinical Trial: A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway inflammation through assessments of mucus plugging and other lung imaging parameters in patients with chronic obstructive pulmonary disease

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'A randomized, double-blind, placebo-controlled study to evaluate the effect of dupilumab on airway ... Read More

Singapore Clinical Trial: CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'CA088-1007: A Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety... Read More

Singapore Clinical Trial: A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lutetium-177 (177Lu) Rosopatamab Tetraxetan in Combination with Standard of Care Versus Standard of Care Alone in Patients with Prostate-Specific Membrane Antigen (PSMA) Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC) after Androgen Receptor Pathway Inhibitor (ARPI) Treatment

Singapore, July 5 -- The Health Sciences Authority received information related to the study titled 'A Multinational, Multicenter, Prospective, Randomized, Controlled, Open-Label, Phase 3 Study of Lut... Read More

OTT: లాక్ అప్ 2 ఓటీటీ షో నుంచి తొలి కంటెస్టెంట్‌గా శ్రేయాస్ అయ్యర్ చెల్లి శ్రేష్ఠ అయ్యర్ ఎలిమినేట్- నటుడిపై కంగనా ఫైర్

భారతదేశం, జూలై 5 -- Shresta Iyer Eliminated From Lock Upp 2 OTT Show: బాలీవుడ్‌లో సంచలనం సృష్టించిన బోల్డ్ రియాలిటీ షో 'లాక్ అప్' సీజన్ 2 (Lock Upp 2: Sach Ya Sazaa) సరికొత్త ట్విస్టులతో దూసుకుపోతోంది... Read More

International mutual funds: Only 12 funds still accept fresh SIPs. See the list

New Delhi, July 5 -- International mutual funds have emerged among the better-performing mutual fund categories over the past year, helped by a rally in global equities and a weaker rupee. Yet, invest... Read More

Young lecturer brings AI, robotics into vocational education

An Giang, July 5 -- Amid the hum of machinery and the rhythmic movements of robotic arms in the training workshop of An Giang Vocational College in An Giang province, lecturer Nguyen Duc Tai patiently... Read More

Virginia State Lottery Issues Solicitation Notice for Flutter Flag Kits and Flags

RICHMOND, Va., July 5 -- Virginia State Lottery has issued a solicitation notice (QQ-123602) on July 2 for Flutter Flag Kits and Flags (Non-professional Services - Non-Technology). Opportunity Type: ... Read More

City of Galax (Virginia) Issues Solicitation Notice for Comprehensive Backflow Prevention Services for City's Cross-Connection Control Program

RICHMOND, Va., July 5 -- City of Galax has issued a solicitation notice (RFP-123606) on July 2 for comprehensive backflow prevention services for the City's cross-connection control program (Professio... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»